Finnish healthcare technology company Deep Sensing Algorithms (DSA) has entered the production phase of their handheld device that measures exhaled breath, intended for healthcare professionals to screen large crowds outside hospitals.
The device is said to detect molecules of biological origin, known as volatile organic compounds (VOC) of carbon dioxide. The sensor data is then transmitted wirelessly to a database server.
The DSA company hails its innovation as fast and easy to use, with a 90% accuracy rate. The device measures the exhaled breath for 15 to 30 seconds, producing results within two minutes, thus measuring the breath of up to 30 patients per hour anywhere with a reliable internet connection.
DSA launched the process in June 2020 and production started last week, almost simultaneously with a tender offer from the UK government. The company now has retailers in 140 countries for whom the selling price averages between €1,000 and €2,000, DSA has confirmed. (Pekka Vänttinen | EURACTIV.com)